Gastroparesis: all 311 studies
Page 3 of 4. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Nutritional Drink in GastroparesisWithdrawnNCT03500354Not applicable
- Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy VolunteersCompletedNCT03441230Not applicable
- Role of Gastric Ultrasound in Preoperative Assessment of Gastric Volume in Diabetic Patients.Status unknownNCT03438305
- Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis SymptomsWithdrawnNCT03376399
- Endoscopic Pyloromyotomy for Refractory GastroparesisCompletedNCT03356067Not applicable
- Gastric Ultrasound for Estimation of the Aspiration Risk StudyCompletedNCT03310528
- Transcutaneous Electroacupuncture for Gastric Complications of SclerodermaCompletedNCT03294616Not applicable
- Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing CholecystectomyCompletedNCT03259841
- Autonomic and Enteric ProfilingCompletedNCT03178370
- Biomagnetic Characterization of Gastric Dysrhythmias IIICompletedNCT03176927Early Phase 1
- Use of Domperidone for Treatment of Upper Gastrointestinal DisordersNo longer availableNCT03128398
- Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory GastroparesisCompletedNCT03126513Not applicable
- Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of GastroparesisCompletedNCT03123809Not applicable
- The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia SymptomsStatus unknownNCT03089632Not applicable
- Naloxegol for Opioid-Related GastroparesisWithdrawnNCT03036891Phase 2
- Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical IllnessCompletedNCT03011151
- Assessment of GI Function to a Large Test Meal by Non-invasive ImagingCompletedNCT03007433Not applicable
- Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting PancreaticoduodenectomyStatus unknownNCT02954302Not applicable
- Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of EfficacyStatus unknownNCT02927886Phase 3
- RQ-00000010 for Gastroparesis and Constipation in Parkinson's DiseaseCompletedNCT02838797Phase 1
- Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study.CompletedNCT02779920Not applicable
- Domperidone for Chronic Nausea and VomitingNo longer availableNCT02757534
- Gastric Emptying in Elderly With Hip FractureCompletedNCT02753010
- Monosodium Glutamate on Gastric EmptyingWithdrawnNCT02745028Not applicable
- G-POEM for Treatment of Refractory GastroparesisCompletedNCT02732821
- Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled TrialStatus unknownNCT02635399Not applicable
- Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled TrialStatus unknownNCT02594397Not applicable
- Domperidone Expanded Access Protocol for Patients With Gastrointestinal DisordersNo longer availableNCT02567175
- Limited Access Protocol for the Use of Oral CisaprideCompletedNCT02524496
- Prucalopride Versus Placebo in GastroparesisTerminatedNCT02510976Phase 4
- Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic GastroparesisStatus unknownNCT02452489Phase 1
- Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic PatientsCompletedNCT02447237Not applicable
- Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlipStatus unknownNCT02446119
- Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by GastroparesisWithdrawnNCT02420925Not applicable
- Reference Values for Gastric EmptyingCompletedNCT02397577Not applicable
- Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 DiabetesCompletedNCT02324010Phase 2
- Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy PeopleStatus unknownNCT02308254Phase 1/2
- Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)CompletedNCT02289846Phase 2
- The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) StudyCompletedNCT02267525Phase 2
- Effects and Mechanism of Mosapride Citrate on Diabetic GastroparesisStatus unknownNCT02264587Phase 4
- Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic GastroparesisStatus unknownNCT02232334Not applicable
- Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy SubjectsCompletedNCT02232308Phase 1
- Treatment Use of Domperidone for GastroparesisNo longer availableNCT02227927
- Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With GastroparesisCompletedNCT02187094Phase 1/2
- Escalating Temporary Gastric Electrical Stimulation (GES) for Severe GastroparesisTerminatedNCT02164591
- Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus NerveCompletedNCT02159586
- Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital StayStatus unknownNCT02086461Not applicable
- The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection.TerminatedNCT02041052Phase 2
- Prucalopride Versus Placebo in GastroparesisCompletedNCT02031081Phase 2/3
- Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive ImagingCompletedNCT01919021Not applicable
- Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic PatientsCompletedNCT01916460Not applicable
- IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the StomachStatus unknownNCT01858220
- Impact of Braun Anastomosis on Reduction in Delayed Gastric Emptying Following PancreaticoduodenectomyCompletedNCT01787955Not applicable
- Phase 2 Study of Velusetrag in Diabetic or Idiopathic GastroparesisCompletedNCT01718938Phase 2
- Gastroparesis Registry 2CompletedNCT01696747
- Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
- Diabetic Gastroparesis Efficacy/Safety Study of TZP-102TerminatedNCT01664637Phase 2
- Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric StasisCompletedNCT01659619Phase 2
- Endoscopic Full Thickness Biopsy, Gastric Wall.CompletedNCT01650714Not applicable
- Acupuncture Treatment for Gastroparesis: a Pilot StudyCompletedNCT01643577Phase 1/2
- Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and GastroparesisCompletedNCT01607684Phase 2
- Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic GastroparesisCompletedNCT01571297Phase 2
- Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic GastroparesisCompletedNCT01557296Phase 2
- Antro-pyloro-duodenal Motility in Idiopathic GastroparesisCompletedNCT01519180
- Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric EmptyingTerminatedNCT01481753Not applicable
- Transcutaneous Electroacupuncture for GastroparesisCompletedNCT01469286Phase 1
- The Effect of Elemental Diet on Gastric EmptyingCompletedNCT01467765Not applicable
- A Prospective Randomized Controlled Multicenter Trial of Delayed Gastric Emptying (DGE) After Pancreaticoduodenectomy Evaluating by Gastrointestinal ReconstructionStatus unknownNCT01460550Phase 3
- Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisCompletedNCT01452815Phase 2
- Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic GastroparesisCompletedNCT01394055Phase 1
- The Use of Domperidone for GastroparesisWithdrawnNCT01378884Phase 3
- Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and CaregiversTerminatedNCT01329211
- Daily Tadalafil and Gastric Emptying Time in Diabetic GastroparesisWithdrawnNCT01326117Phase 4
- Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis SymptomsCompletedNCT01316484
- FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese VolunteersCompletedNCT01294566Phase 1
- An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes MellitusTerminatedNCT01286090Phase 4
- An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment OptionsTerminatedNCT01281540Phase 4
- A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy VolunteersCompletedNCT01267071Phase 1
- Reconstruction Method and Delayed Gastric Emptying After Pancreatic SurgeryCompletedNCT01248663Not applicable
- Gastric Emptying After Infracolic or Supracolic Gastrojejunostomy Following PancreaticoduodenectomyCompletedNCT01191138Not applicable
- Idiopathic Gastroparesis Registry Using a Predominant-Symptom ClassificationTerminatedNCT01173484
- Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted InterventionCompletedNCT01126034Not applicable
- Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill PatientsTerminatedNCT01117376Phase 2
- Safety and Pharmacokinetic Study of C13-URA in Healthy VolunteersCompletedNCT01074710Phase 1
- Temporary Gastric Electrical Stimulation for GastroparesisCompletedNCT01054794Not applicable
- GSK962040 Drug-drug Interaction Study With KetoconazoleCompletedNCT01039974Phase 1
- Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed IntoleranceCompletedNCT01039805Phase 2
- Gastric vs Jejunal Feeding in Diabetic GastroparesisWithdrawnNCT00944593Phase 4
- Medico-economic Evaluation of ENTERRA TherapyCompletedNCT00903799Not applicable
- Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes MellitusCompletedNCT00889486Phase 2
- The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With GastroparesisCompletedNCT00861809Phase 2
- Domperidone for Refractory Gastrointestinal DisordersStatus unknownNCT00777439Not applicable
- The Effect of Oxytocin on the Gastric EmptyingCompletedNCT00776360Early Phase 1
- Domperidone for Relief of Gastrointestinal DisordersTerminatedNCT00761254Not applicable
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.CompletedNCT00733551Phase 1
- A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years OldCompletedNCT00682877
- Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic GastroparesisCompletedNCT00639808Phase 1
- Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal GastrectomyWithdrawnNCT00622804Phase 3
- Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic GastroparesisCompletedNCT00612014Phase 2
- Gastric Pacemaker Implantation for GastroparesisWithdrawnNCT00568373Not applicable